Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019
May 14 2019 - 8:05AM
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the
commercialization and development of prescription ophthalmic
pharmaceuticals, announces that President and CEO, Rick Eiswirth
will present a corporate overview and meet with investors at the
20th Annual B. Riley FBR Institutional Investor Conference on May
22, 2019.
Mr. Eiswirth’s presentation will be held at 2:00 PM PT in Room 9
of the Beverly Hilton Hotel, 9876 Wilshire Blvd. in Beverly Hills,
Calif. Investors interested in one-on-one meetings should
contact the conference organizers at
conference@brileyfbr.com.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company that
specializes in the commercialization and development of
prescription ophthalmic pharmaceuticals. Alimera is presently
focused on diseases affecting the back of the eye, or retina,
because these diseases are not well treated with current therapies
and will affect millions of people in our aging populations. For
more information, please visit www.alimerasciences.com.
For Investor Inquiries: Scott Gordon for Alimera
Sciences scottg@coreir.com |
For press inquiries:Jules Abrahamfor Alimera
Sciences 917-885-7378julesa@coreir.com |
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Apr 2023 to Apr 2024